Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Methods in Molecular Biology (Clifton, N.J.)|May 6, 2020
Zika Virus Isolation, Purification, and TitrationMariana BazPharmaceuticals (Basel, Switzerland)|July 3, 2019
Antiviral Agents in Development for Zika Virus InfectionsMariana Baz, Guy BoivinAntiviral Therapy|February 17, 2007
Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgroundsYacine Abed, Mariana Baz, Guy BoivinPlos Pathogens|May 13, 2022
Preclinical and clinical developments for combination treatment of influenzaPaulina Koszalka, Kanta Subbarao, Mariana BazThe Journal of Infectious Diseases|December 3, 2008
A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virusYacine Abed, Mariana Baz, Guy BoivinAntiviral Research|December 2, 2006
Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivirMariana Baz, Yacine Abed, Guy BoivinAntimicrobial Agents and Chemotherapy|November 19, 2008
Activity of the oral neuraminidase inhibitor A-322278 against the oseltamivir-resistant H274Y (A/H1N1) influenza virus mutant in miceMariana Baz, Yacine Abed, Benjamin Nehmé, et al.Antiviral Research|October 9, 2007
Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypesYacine Abed, Benjamin Nehmé, Mariana Baz, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2006
Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised childMariana Baz, Yacine Abed, Jane McDonald, et al.Journal of the American Chemical Society|December 22, 2016
Structural Insight into NS5 of Zika Virus Leading to the Discovery of MTase InhibitorsPreyesh Stephen, Mariana Baz, Guy Boivin, et al.Pageof 7